Skip to content

The impact of COVID-19 infection on pregnancy outcome during ovulation of IVF-ET

The impact of COVID-19 infection on pregnancy outcome during ovulation of IVF-ET

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072380
Enrollment
Unknown
Registered
2023-06-12
Start date
2023-06-15
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 infection

Interventions

Sponsors

Qingdao Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients =40 years old undergoing IVF-ET. 2. Patients infected with novel coronavirus (CoV-positive or Cov-antigen-positive) during ovulation induction.

Exclusion criteria

Exclusion criteria: 1. Patients with fertilization disorder after multiple previous ovulation; 2. Patients with acute inflammation, patients with severe allergic constitution, patients with severe liver, kidney, heart, lung dysfunction and other endocrine system diseases are excluded.

Design outcomes

Primary

MeasureTime frame
rate of fertilization;rate of high quality embryo;

Secondary

MeasureTime frame
Blastocyst formation rate;thickness of endometrium on HCG day;E2 level on HCG day;

Countries

China

Contacts

Public ContactYangying Xu

Qingdao Women and Children's Hospital

rosy1999@126.com+86 137 9181 0932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026